88057-57-2

Upstream product

• 75842-16-9 (+/-)-2-amino-α-phenylbenzeneethanamine 
• 22751-23-1 (2-nitrophenyl)acetyl chloride 
• 4212-33-3 2-(2-nitrophenyl)-1-phenylethanone 
• 15582-92-0 2-(2-nitrophenyl)-1-phenylethanone oxime 
• 75842-14-7 2-(2-nitrophenyl)-1-phenylethanone oxime acetate 
• 75842-78-3 (+/-)-2-nitro-α-phenylbenzeneethanamine 
• 71-43-2 benzene 

Relevant academic research and scientific papers

(±)-4-Aryl-4,5-dihydro-3H-1,3-benzodiazepines. 3. 2-Phenyl and 2-amino analogues as potential antihypertensive agents

A series of 2-phenyl- and 2-amino-4-aryl-4,5-dihydro-3H-1,3-benzodiazepines was prepared and submitted for broad biological screening, including evaluation for potential antihypertensive activity. Compound 4a [(±)-4,5-dihydro-2,4-diphenyl-3-methyl-3H-1,3-benzodiazepine hydrochloride] was the most active member of the series in the spontaneously hypertensive rat (SHR) model, producing a 56 mmHg decrease in systolic blood pressure at an oral screening dose of 50 mg/kg. The synthesis of 4a analogues containing nuclear substituents in the 4-phenyl moiety resulted in a marked decrease of antihypertensive activity. It was not possible to improve on the antihypertensive properties of 4a through further synthetic modifications.

(+/-)-4-Aryl-4,5-dihydro-3H-1,3-benzodiazepines. 1. Synthesis and Evaluation of (+/-)-4,5-Dihydro-2,3-dimethyl-4-phenyl-3H-1,3-benzodiazepine and Analogues as Potential Antidepressant Agents

A series of (+/-)-4,5-dihydro-4-phenyl-3H-1,3-benzodiazepines and (+/-)-4,5-dihydro-4-phenyl-1H-1,3-benzodiazepines was synthesized as part of a program to develop novel psychotropics.Of these compounds, (+/-)-4,5-dihydro-2,3-dimethyl-4-phenyl-3H-1,3-benz